⌘K

Login Start Free

Home/Filings/4/0001415889-23-000041

4//SEC Filing

Singh Shawn 4

Accession 0001415889-23-000041

CIK 0001411685other

View on SEC.gov Company Profile

Filed

Jan 2, 7:00 PM ET

Accepted

Jan 3, 4:10 PM ET

Size

5.5 KB

Accession

0001415889-23-000041

Insider Transaction Report

Form 4

Period: 2022-12-30

VistaGen Therapeutics, Inc.VTGN

DirectorCHIEF EXECUTIVE OFFICER

Transactions

Award
Common Stock
2022-12-30$0.09/sh+5,000$438→ 158,998 total

Holdings

Common Stock
(indirect: By Trust)
626,234

Footnotes (1)

[F1]Shares purchased under the Vistagen Therapeutics, Inc. 2019 Employee Stock Purchase Plan ("ESPP").

Documents

1 file

4
form4-01032023_090116.xmlPrimary

Issuer

VistaGen Therapeutics, Inc.

CIK 0001411685

Entity typeother

Related Parties

1

filerCIK 0001412071

Filing Metadata

Form type: 4
Filed: Jan 2, 7:00 PM ET
Accepted: Jan 3, 4:10 PM ET
Size: 5.5 KB

View on SEC.gov